Institutional investors hold a majority ownership of ILMN through the 92.95% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FEDERATED GLOBAL INVESTMENT MANA... Bought 472.5 Thousand shares of Illumina Inc
JACKSON SQUARE PARTNERS LLC Bought 344.5 Thousand shares of Illumina Inc
QUANTITATIVE MANAGEMENT ASSOCIAT... Bought 325.0 Thousand shares of Illumina Inc